30 mcg ethinylestradiol/3 mg drospirenone

DRUG2 trials

Sponsors

Mahidol University, Tyumen State Medical Academy

Conditions

Body Weight ChangesHyperandrogenismMenstrual IrregularitiesPolycystic Ovarian Syndrome

Phase 4

Comparison of Body Weight Change During Contraception With Belara and Yasmin

Mahidol UniversityBody Weight Changes

Start: 2012-06-30End: 2016-02-29Target: 100Updated: 2015-04-09

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Tyumen State Medical AcademyHyperandrogenism, Menstrual Irregularities, Polycystic Ovarian Syndrome

Start: 2013-12-31End: 2015-10-31Target: 200Updated: 2014-11-21

Related Papers

Comparison of change in body weight between contraception containing 30-μg ethinylestradiol/2-mg chlormadinone acetate or 30-μg ethinylestradiol/3-mg drospirenone: a randomised controlled trial

The European Journal of Contraception & Reproductive Health Care2019-11-223 citations